event · scholar-spotlight
Join ARCS Scholar Alum Eric DeJesus, PhD (Founder & CEO, Annate Bitherapeutics) on June 10 as he discusses innovative cancer-targeting immunotherapies. Read More ›
press-release · recognition
The University of Georgia highlighted Annate Bitherapeutics at the inaugural Southeastern Venture Showcase in Nashville, recognizing the company among a select group of early-stage ventures advancing research-driven innovation. Read More ›
press-release · fund-raising
The Southeast Venture Showcase is a transformational event that empowers research universities and federal laboratories across the Southeast to showcase their most promising technology ventures for the nation’s venture community. Read More ›
press-release · funding
The Lesinski and Hajduk labs awarded $50,000 to develop relevant models for ApoL1 based therapies. Read More ›
press-release · funding
In recognition of the significant strides made in Phase Ia and Phase Ib, the Georgia Research Alliance has awarded a $25,000 Phase Ic grant to Annate Bitherapeutics and the Hajduk Lab at the University of Georgia. This grant will specifically support the advancement of proof-of-concept animal studies, a critical step in the development of their innovative therapeutic against Multiple Myeloma. Read More ›